Vor Biopharma, Inc. (VOR)
24.00
+1.28
(+5.66%)
USD |
NASDAQ |
Aug 25, 16:00
24.00
0.00 (0.00%)
After-Hours: 16:23
Vor Biopharma Price to Book Value
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| June 27, 2025 | 40.06 |
| June 26, 2025 | 33.64 |
| June 25, 2025 | 20.95 |
| June 24, 2025 | 12.02 |
| June 23, 2025 | 10.96 |
| June 20, 2025 | 9.082 |
| June 18, 2025 | 8.088 |
| June 17, 2025 | 7.793 |
| June 16, 2025 | 8.379 |
| June 13, 2025 | 6.882 |
| June 12, 2025 | 7.823 |
| June 11, 2025 | 8.315 |
| June 10, 2025 | 8.674 |
| June 09, 2025 | 8.424 |
| June 06, 2025 | 8.458 |
| June 05, 2025 | 8.451 |
| June 04, 2025 | 8.644 |
| June 03, 2025 | 8.375 |
| June 02, 2025 | 8.855 |
| May 30, 2025 | 7.555 |
| May 29, 2025 | 7.374 |
| May 28, 2025 | 6.708 |
| May 27, 2025 | 6.557 |
| May 23, 2025 | 6.674 |
| May 22, 2025 | 7.06 |
| Date | Value |
|---|---|
| May 21, 2025 | 6.905 |
| May 20, 2025 | 6.746 |
| May 19, 2025 | 6.633 |
| May 16, 2025 | 6.686 |
| May 15, 2025 | 6.459 |
| May 14, 2025 | 6.463 |
| May 13, 2025 | 6.047 |
| May 12, 2025 | 6.520 |
| May 09, 2025 | 5.718 |
| May 08, 2025 | 6.047 |
| May 07, 2025 | 20.24 |
| May 06, 2025 | 21.35 |
| May 05, 2025 | 22.84 |
| May 02, 2025 | 25.00 |
| May 01, 2025 | 24.98 |
| April 30, 2025 | 25.67 |
| April 29, 2025 | 25.70 |
| April 28, 2025 | 26.37 |
| April 25, 2025 | 27.21 |
| April 24, 2025 | 27.49 |
| April 23, 2025 | 28.69 |
| April 22, 2025 | 26.53 |
| April 21, 2025 | 25.94 |
| April 17, 2025 | 24.57 |
| April 16, 2025 | 24.57 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Dyne Therapeutics, Inc. | 6.213 |
| Agenus, Inc. | -- |
| Amgen, Inc. | 20.47 |
| Anika Therapeutics, Inc. | 2.098 |
| BioCryst Pharmaceuticals, Inc. | -- |
Price to Book Value Related Metrics
| Price | 24.00 |
| Earnings Yield | -347.5% |
| Market Cap | 1.307B |